Key result
Randomized trial compares precision focal ostial vs. provisional stenting for branch ostial bifurcation lesions.
Why the study?
Isolated branch ostial coronary bifurcation lesions (Medina 0,1,0 and 0,0,1) are among the least studied lesion subsets in PCI. Although provisional stenting and focal ostial stenting are both commonly used in clinical practice, no randomised controlled trial has directly compared these two approaches.
Does precision focal ostial stenting reduce target lesion failure at 24 months compared to provisional stenting in patients undergoing PCI for isolated branch ostial coronary bifurcation lesions?
RCT (n=274)
Open-label (with blinded clinical event adjudication)
1:1 ratio
Yes
Does precision focal ostial stenting reduce target lesion failure at 24 months compared to provisional stenting in patients undergoing PCI for isolated branch ostial coronary bifurcation lesions?
This study describes the rationale and design of the PROST trial, the first randomized controlled trial directly comparing provisional versus precision focal ostial stenting for isolated branch ostial coronary bifurcation lesions.
Answers are grounded in this paper and cite their sources.
Should not yet change bifurcation PCI practice while awaiting 24-month outcomes; leaves open whether imaging-guided focal ostial stenting improves upon provisional strategies.
BACKGROUND: Isolated branch ostial coronary bifurcation lesions (Medina 0,1,0 and 0,0,1) remain one of the least studied lesion subsets in percutaneous coronary intervention (PCI). Two techniques, provisional stenting and focal ostial stenting, are commonly used in clinical practice. However, no randomised controlled trial has directly compared these treatment approaches. METHOD: The PRovisional vs Precision OSTial Stenting (PROST) trial is a prospective, multicentre, open-label, randomised controlled trial comparing provisional stenting with precision focal ostial stenting in patients undergoing PCI for isolated branch ostial coronary bifurcation lesions. A total of 274 patients will be randomised in a 1:1 ratio across participating Australasian centres. The trial is embedded within the Australasian Bifurcation Coronary Registry and incorporates mandatory intravascular imaging guidance, independent angiographic core laboratory assessment, and blinded clinical event adjudication. The primary endpoint is target lesion failure at 24 months, defined according to Bifurcation Academic Research Consortium criteria. CONCLUSIONS: To our knowledge, the PROST trial is the first randomised study evaluating provisional versus precision focal ostial stenting for isolated branch ostial coronary bifurcation lesions. Its findings will address an important evidence gap and have the potential to inform future clinical practice and guideline recommendations.
No takes yet. Share an insight, caveat, or question.
Ekmejian et al. (2026) conducted an RCT in Isolated branch ostial coronary bifurcation lesions (Medina 0,1,0 and 0,0,1) (n=274). Provisional stenting vs. Precision focal ostial stenting was evaluated on Target lesion failure at 24 months, defined according to Bifurcation Academic Research Consortium criteria. Provisional versus precision focal ostial stenting will be compared in 274 randomized patients with isolated branch ostial bifurcation lesions for 24-month target lesion failure (protocol only).
Synapse has enriched 10 related papers. Consider them for comparative context: